statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Biolase price target lowered by $2.10 at Benchmark, here's why

Q4 2023 BIOLASE Inc Earnings Call Transcript

Gagnants
Le titre Biolase (NASDAQ:BIOL) a augment vendredi de 61,13% 0,24 dollars lors de la session pre-market. D'apr s le communiqu de presse, les b n fices au deuxi me quatri me trimestre ont...

12 titres de soins de sant  en mouvement lors de la pr -ouverture le 22/03/2024

Acciones al alza
Biolase (NASDAQ:BIOL) ganaron un 23,33% para establecerse en los 0,18 d lares durante la sesi n del after-market del jueves. Las ganancias de cuarto trimestre de la compa a se han...

12 acciones de salud en movimiento en la subasta de cierre del 21/03/2024

Recap: Biolase Q4 Earnings

Biolase GAAP EPS of -$1.76 beats by $0.80, revenue of $13.49M beats by $0.27M...

Biolase GAAP EPS of -$1.76 beats by $0.80, revenue of $13.49M beats by $0.27M

LAKE FOREST, CA / ACCESSWIRE / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, who previously announced its preliminary financial results for...

Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024

Biolase (NASDAQ:BIOL) render noti i prossimi risultati degli utili gioved 21 marzo. Ecco la guida di Benzinga con tutte le informazioni pi importanti per la pubblicazione degli utili.
Cosa sono...

Un'anteprima degli utili di Biolase

Biolase (NASDAQ:BIOL) anuncia su pr xima ronda de ganancias este jueves, 21 de marzo. Esta es la gu a de Benzinga con la informaci n m s importante para esta presentaci n de resultados del cuarto...

Pron stico de resultados para Biolase

LAKE FOREST, CA / ACCESSWIRE / March 14, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release fourth quarter and full...

BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.

Volume	546,367.00
52-Wk High	$32.09
52-Wk Low	$0.1251

BIOL Biolase Inc

About

Feed

News

Fundamentals